CoChat

The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma

Open access
Chee, Cheng E., Kumar, Shaji, Larson, Dirk R., Kyle, Robert A., Dispenzieri, Angela, Gertz, Morie A., Colby, Colin L., Rajkumar, S. Vincent · 2009 · Blood
Cited by 51

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

The current definition of complete response in multiple myeloma includes a requirement for a bone marrow (BM) examination showing less than 5% plasma cells in addition to negative serum and urine immunofixation. There have been suggestions to eliminate the need for BM examinations when defining complete response. We evaluated 92 patients with multiple myeloma who achieved negative immunofixation in the serum and urine after therapy and found that 14% had BM plasma cells more than or equal to 5%. Adding a requirement for normalization of the serum-free light chain ratio to negative immunofixation studies did not negate the need for BM studies; 10% with a normal serum-free light chain ratio had BM plasma cells more than or equal to 5%. We also found that, on achieving immunofixation-negative status, patients with less than 5% plasma cells in the BM had improved overall survival compared with those with 5% or more BM plasma cells (6.2 years vs 2.3 years, respectively; P = .01).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2009-01-198788

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 51

Metadata

Authors
Chee, C. E., Kumar, S., Larson, D. R., Kyle, R. A., Dispenzieri, A., Gertz, M. A., Colby, C. L., & Rajkumar, S. V.
Venue
Blood
Published
2009-09-24
Volume
114
Issue
13
Pages
2617-2618
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2036702941
Cited by
51
References
1
FWCI
2.77
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma. https://app.cochat.ai/papers/10.1182/blood-2009-01-198788
The paper
Chee, C. E., Kumar, S., Larson, D. R., Kyle, R. A., Dispenzieri, A., Gertz, M. A., Colby, C. L., & Rajkumar, S. V. (2009). The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma. Blood. https://doi.org/10.1182/blood-2009-01-198788

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.